A Phase 2 Study of siG12D LODER in Combination with Chemotherapy in Patients with
John Theurer Cancer Center at Hackensack Meridian Health Hackensack University Medical Center is 1 of 4 academic medical centers in the U.S. to participate in a cutting-edge Phase 2 multinational clinical trial of gene therapy for previously untreated, Inoperable pancreatic cancer.
Excellence is Our Standard
At Hackensack Meridian Health, we are committed to achieving the highest quality standards and outcomes and welcome the clarity that measurement and reporting bring to the process. We are committed to transparency; shining a spotlight on safety, patient experience, and other publicly reported measures that accelerates improvement.
View our latest commercial
At Hackensack Meridian Health we believe the best health care is perfectly orchestrated. Check out our commercial to see how we're providing everything you need - from primary care to emergency care, home health to rehab - to help you feel your best.
Share your story with us.
Those who have had the pleasure of meeting co-CEO of Hackensack Meridian Health John K. Lloyd, FACHE, know his legacy goes far beyond the incredible health network he helped build. John’s warm, caring personality and vibrant presence make him stand out as one of the most loved and respected leaders in health care. Join us in honoring John K. Lloyd, retiring in December 2018.
Memorial Sloan Kettering and Hackensack Meridian Health host ongoing complimentary interactive community talks featuring cancer experts.